Trial Profile
To detect correlation between CXCL4 serum levels and any disease feature in rheumatoid arthritis patients treated with Adalimumab and Tocilizumab.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Aug 2016
Price :
$35
*
At a glance
- Drugs Abatacept (Primary) ; Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 23 Aug 2016 New trial record